Expertise in
9
conditions

Karl-ludwig L. Laugwitz

Ismaninger Str. 22, 
Munich, BY, DE 
Expertise in
9
conditions
Ismaninger Str. 22, 
Munich, BY, DE 

Overview

Karl-ludwig Laugwitz practices practicing medicine in Munich, Germany.

Laugwitz is highly rated in 9 conditions, according to our data. Their clinical expertise encompasses Coronary Heart Disease, Heart Attack, Acute Coronary Syndrome, Stent Placement, and Percutaneous Coronary Intervention (PCI).

They are actively involved in clinical research, co-authoring 378 peer reviewed articles and participating in 4 clinical trials.

Locations

Ismaninger Str. 22, Munich, BY 81675, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
Enrollment Status: Completed
Publish Date: March 26, 2025
Intervention Type: Diagnostic test
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drugs: Ticagrelor, Prasugrel
Study Phase: Phase 4
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Enrollment Status: Completed
Publish Date: April 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
Intracoronary Stenting and Angiographic Results: ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
Intracoronary Stenting and Angiographic Results: ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography
Enrollment Status: Completed
Publish Date: August 04, 2017
Intervention Type: Device, Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

378 Total Publications

Peripheral stent thrombosis: Impact of anticoagulation strategies and diagnostic role of platelet aggregometry.
Peripheral stent thrombosis: Impact of anticoagulation strategies and diagnostic role of platelet aggregometry.
Journal: VASA. Zeitschrift fur Gefasskrankheiten
Published: July 23, 2026

Frequently Asked Questions about Karl-ludwig L. Laugwitz

Is Karl-ludwig L. Laugwitz a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Karl-ludwig L. Laugwitz is classified as an Distinguished expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Karl-ludwig L. Laugwitz participate in research or clinical trials?

Yes. Karl-ludwig L. Laugwitz has published 378 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Karl-ludwig L. Laugwitz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Laugwitz's expertise for a condition
ConditionClose
    View All 46 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile